Boeing stock sank 4% in overnight trading. Sunday, Jeju Air flight 2216 carrying 181 passengers and crew traveling from Thailand to South Korea crashed on landing, tragically killing most on board.

The plane involved was a Boeing 737-800 jet. That isn't a 737 MAX jet, which is the model closely monitored by investors since two tragic MAX crashes grounded that jet worldwide between March 2019 and November 2020. The two MAX jets were relatively new and the problem was traced back to faulty flight control software.

The Jeju plane was manufactured in 2009, and Jeju started flying it in 2017. The airline, in a news release, said the regular inspections had been completed before takeoff.

Drone maker companies continued to rally in overnight trading. Ondas Holdings rose 15%; Palladyne AI soared 14% after a 61% rally in prior session; SES AI rose 6.7%; Unusual Machines up 2.4%.

Faraday Future stock continued to jump 25.6% in overnight trading after soaring 33% on Friday.

Faraday Future has secured approximately $30 million in financing, consisting of $22.5 million in cash and $7.5 million converted from previous loans. This funding will support the company’s growth, particularly the development of its Faraday X (FX) strategy, which focuses on launching affordable, high-performance AIEVs in the U.S. market. The financing involves the issuance of unsecured convertible notes and warrants, and is expected to strengthen the company’s core business operations and facilitate the production of its FF 91 2.0 model and the FX brand.

Assembly Biosciences stock rose 7.65% in overnight trading. Gilead Sciences bought a large block of shares of antiviral-therapeutics developer Assembly Biosciences as part of an amended investment and funding agreement.

Gilead paid $20.1 million on Dec. 19 for 940,500 Assembly shares, an average price of $21.37 each. Gilead now owns 2.21 million Assembly shares, a 29.9% stake, according to a form Gilead filed with the Securities and Exchange Commission. The shares were newly issued by Assembly, and represented a 35% premium to a calculated 30-day volume-weighted average price immediately before the date of purchase.